Stay updated on Roxadustat in End-Stage Renal Disease Clinical Trial
Sign up to get notified when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.

Latest updates to the Roxadustat in End-Stage Renal Disease Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page's revision label was updated: Revision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

- Check22 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check51 days agoChange DetectedAdded: Revision: v3.4.2; Removed: Notice about funding lapse and operating status (v3.4.1).SummaryDifference0.3%

- Check58 days agoChange DetectedAdded a government funding notice about site status (cc.nih.gov and opm.gov) and updated the page revision to v3.4.1, replacing v3.4.0.SummaryDifference0.3%

- Check65 days agoChange DetectedAdded a 'Show glossary' option and a new 'Revision: v3.4.0' tag, with updated QC metadata labeling ('Last Update Submitted that Met QC Criteria') and a new 'No FEAR Act Data' note.SummaryDifference0.2%

- Check72 days agoChange DetectedSponsor attribution changed from FibroGen to Kyntra Bio in the study record. This updates the organization responsible for the study and related contact information.SummaryDifference0.2%

Stay in the know with updates to Roxadustat in End-Stage Renal Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat in End-Stage Renal Disease Clinical Trial page.